虚拟筛选
计算生物学
分子模型
化学
对接(动物)
药物发现
分子描述符
化学相似性
分子动力学
体内
药品
天然产物
生物信息学
优先次序
生物化学
广告
组合化学
同源建模
体外
化学信息学
结构-活动关系
结构相似性
氨基酸
活动站点
装订袋
精氨酸
小分子
铅化合物
药理学
蛋白质-蛋白质相互作用
靶蛋白
诱饵
血浆蛋白结合
蛋白质结构
药物开发
天然产物研究
分子力学
作者
Bryan German Pineda-Cagua,Sofía Ruiz-Hernández,Fátima de Lourdes Ochoa-González,Julio Enrique Castañeda‐Delgado,Alfredo Juárez-Saldívar,Gildardo Rivera Sánchez,Edgar Eduardo Lara-Ramirez
标识
DOI:10.2174/0113894501488854260831064519
摘要
BACKGROUND: Natural products serve as vital scaffolds for novel drug discovery. PAD4 is an attractive target dysregulated in chronic diseases like Alzheimer's, cancer, and rheumatoid arthritis. Given the lack of clinically approved synthetic inhibitors, exploring structurally diverse natural products offers a promising strategy for novel drug development. METHODS: Molecular modeling using ligand-based virtual screening, consensus molecular docking using four scoring functions available on the Smina and Vina software, ADME-Tox consensus filtering, and molecular dynamics analysis with GROMACS were applied to virtually screen natural products from the COCONUT database as potential PAD4 binders. RESULTS: The docking validation parameters (redocking RMSD < 2 Å, AUC-ROC > 70 %) confirmed the effective discrimination of known PAD4 inhibitors from decoys. From the COCONUT database, 29,164 compounds were initially filtered by similarity to noncovalent PAD4 inhibitors. Among these, 10 compounds were selected as the top candidate inhibitors using a multi-faceted virtual screening protocol that combined a novel consensus pharmacological score with binding affinity, druglikeness, and ADMET evaluations. PASS predictions further corroborated their PAD4 inhibitory potential. Molecular dynamics of the top five compounds confirmed active-site stability and noncovalent interactions with catalytic residues Asp350, Arg374, His471, Asp473, and Cys645. Structurally, these candidates represent diverse natural chemical classes, including benzenoids, alkaloids, and amino acid derivatives. DISCUSSION: The multifaceted virtual screening conducted in this work resulted in confident prioritization of five potential PAD4 inhibitors. Further in vitro and in vivo studies are needed to confirm their functional inhibitory activity in diseases in which this target is dysregulated. CONCLUSION: Five natural chemistry-binders of PAD4 were identified by detailed molecular modeling studies. They could be used as chemical scaffolds for future medicinal chemistry drug design.
科研通智能强力驱动
Strongly Powered by AbleSci AI